{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:38:53Z","timestamp":1793176733446,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms6797","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T13:52:10Z","timestamp":1418392330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis"],"prefix":"10.1038","volume":"5","author":[{"given":"Shinji","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Fujiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Saigusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Akamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"BFncomms6797_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga, J. & Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557\u2013567 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6797_CR2","first-page":"115","volume":"1","author":"A Leask","year":"2009","unstructured":"Leask, A. Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma. Front. Biosci. (Elite Ed) 1, 115\u2013122 (2009).","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"BFncomms6797_CR3","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/art.24620","volume":"60","author":"M Ponticos","year":"2009","unstructured":"Ponticos, M. et al. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 60, 2142\u20132155 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR4","doi-asserted-by":"publisher","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"ML Whitfield","year":"2003","unstructured":"Whitfield, M. L. et al. Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc. Natl Acad. Sci. USA 100, 12319\u201312324 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6797_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K","volume":"181","author":"T Mori","year":"1999","unstructured":"Mori, T. et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J. Cell. Physiol. 181, 153\u2013159 (1999).","journal-title":"J. Cell. Physiol."},{"key":"BFncomms6797_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-4-4","volume":"4","author":"Q Wang","year":"2011","unstructured":"Wang, Q. et al. Cooperative interaction of CTGF and TGF-\u03b2 in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4, 4 (2011).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFncomms6797_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","volume":"59","author":"Y Asano","year":"2010","unstructured":"Asano, Y., Bujor, A. M. & Trojanowska, M. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. J. Dermatol. Sci. 59, 153\u2013162 (2010).","journal-title":"J. Dermatol. Sci."},{"key":"BFncomms6797_CR8","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.21948","volume":"54","author":"Y Wang","year":"2006","unstructured":"Wang, Y., Fan, P. S. & Kahaleh, B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 54, 2271\u20132279 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR9","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00018-009-0045-z","volume":"66","author":"JT Dong","year":"2009","unstructured":"Dong, J. T. & Chen, C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell. Mol. Life Sci. 66, 2691\u20132706 (2009).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFncomms6797_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1172\/JCI40295","volume":"120","author":"N Takeda","year":"2010","unstructured":"Takeda, N. et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest. 120, 254\u2013265 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6797_CR11","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1172\/JCI57582","volume":"121","author":"K Fujiu","year":"2011","unstructured":"Fujiu, K., Manabe, I. & Nagai, R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J. Clin. Invest. 121, 3425\u20133441 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6797_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nm738","volume":"8","author":"T Shindo","year":"2002","unstructured":"Shindo, T. et al. Kr\u00fcppel-like zinc-finger transcription factor KLF5\/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8, 856\u2013863 (2002).","journal-title":"Nat. Med."},{"key":"BFncomms6797_CR13","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","volume":"20","author":"DD Spyropoulos","year":"2000","unstructured":"Spyropoulos, D. D. et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol. Cell. Biol. 20, 5643\u20135652 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6797_CR14","doi-asserted-by":"crossref","unstructured":"Altorok, N., Almeshal, N., Wang, Y. & Kahaleh, B. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford) PMID 24740406 (2014).","DOI":"10.1093\/rheumatology\/keu155"},{"key":"BFncomms6797_CR15","doi-asserted-by":"crossref","unstructured":"Altorok, N., Tsou, P. S., Coit, P., Khanna, D. & Sawalha, A. H. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann. Rheum. Dis. PMID 24812288 (2014).","DOI":"10.1136\/annrheumdis-2014-205303"},{"key":"BFncomms6797_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","volume":"41","author":"Y Luo","year":"2013","unstructured":"Luo, Y., Wang, Y., Wang, Q., Xiao, R. & Lu, Q. Systemic sclerosis: genetics and epigenetics. J. Autoimmun. 41, 161\u2013167 (2013).","journal-title":"J. Autoimmun."},{"key":"BFncomms6797_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","volume":"112","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto, T. et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J. Invest. Dermatol. 112, 456\u2013462 (1999).","journal-title":"J. Invest. Dermatol."},{"key":"BFncomms6797_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20101629","volume":"208","author":"C Dees","year":"2011","unstructured":"Dees, C. et al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J. Exp. Med. 208, 961\u2013972 (2011).","journal-title":"J. Exp. Med."},{"key":"BFncomms6797_CR19","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/ar1890","volume":"8","author":"JP Van Beek","year":"2006","unstructured":"Van Beek, J. P., Kennedy, L., Rockel, J. S., Bernier, S. M. & Leask, A. The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res. Ther. 8, R36 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"BFncomms6797_CR20","doi-asserted-by":"publisher","first-page":"25259","DOI":"10.1074\/jbc.M600466200","volume":"281","author":"SS Nakerakanti","year":"2006","unstructured":"Nakerakanti, S. S., Kapanadze, B., Yamasaki, M., Markiewicz, M. & Trojanowska, M. Fli1 and Ets1 have distinct roles in connective tissue growth factor\/CCN2 gene regulation and induction of the profibrotic gene program. J. Biol. Chem. 281, 25259\u201325269 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6797_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/1523-1747.ep12462561","volume":"90","author":"JS Perlish","year":"1988","unstructured":"Perlish, J. S., Lemlich, G. & Fleischmajer, R. Identification of collagen fibrils in scleroderma skin. J. Invest. Dermatol. 90, 48\u201354 (1988).","journal-title":"J. Invest. Dermatol."},{"key":"BFncomms6797_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/MCB.01278-08","volume":"29","author":"Y Asano","year":"2009","unstructured":"Asano, Y. et al. Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol. Cell. Biol. 29, 425\u2013434 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6797_CR23","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli, A., Avvedimento, E. V. & Krieg, T. Scleroderma. N. Engl. J. Med. 360, 1989\u20132003 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms6797_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","volume":"14","author":"M Manetti","year":"2010","unstructured":"Manetti, M., Guiducci, S., Ibba-Manneschi, L. & Matucci-Cerinic, M. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J. Cell. Mol. Med. 14, 1241\u20131254 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"BFncomms6797_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/rheumatology\/kep066","volume":"48","author":"N Mugii","year":"2009","unstructured":"Mugii, N. et al. Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. Rheumatology (Oxford) 48, 696\u2013703 (2009).","journal-title":"Rheumatology (Oxford)"},{"key":"BFncomms6797_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler, O. et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ. Res. 95, 109\u2013116 (2004).","journal-title":"Circ. Res."},{"key":"BFncomms6797_CR27","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","volume":"176","author":"Y Asano","year":"2010","unstructured":"Asano, Y. et al. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am. J. Pathol. 176, 1983\u20131998 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFncomms6797_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/cvr\/cvp220","volume":"84","author":"R Kundi","year":"2009","unstructured":"Kundi, R. et al. Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc. Res. 84, 326\u2013335 (2009).","journal-title":"Cardiovasc. Res."},{"key":"BFncomms6797_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros, D. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 165, 1581\u20131586 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFncomms6797_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","volume":"38","author":"P Dorfm\u00fcller","year":"2007","unstructured":"Dorfm\u00fcller, P. et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum. Pathol. 38, 893\u2013902 (2007).","journal-title":"Hum. Pathol."},{"key":"BFncomms6797_CR31","doi-asserted-by":"publisher","first-page":"L330","DOI":"10.1152\/ajplung.00270.2010","volume":"300","author":"S Chen","year":"2011","unstructured":"Chen, S. et al. CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L330\u2013L340 (2011).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFncomms6797_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/01.bor.0000179945.73518.28","volume":"17","author":"M Fujimoto","year":"2005","unstructured":"Fujimoto, M. & Sato, S. B lymphocytes and systemic sclerosis. Curr. Opin. Rheumatol. 17, 746\u2013751 (2005).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFncomms6797_CR33","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1002\/art.22847","volume":"56","author":"R Lafyatis","year":"2007","unstructured":"Lafyatis, R., O\u2019Hara, C., Feghali-Bostwick, C. A. & Matteson, E. B cell infiltration in systemic sclerosis-associated interstitial lung disease. Arthritis Rheum. 56, 3167\u20133168 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/2162-3619-1-36","volume":"1","author":"K Wang","year":"2012","unstructured":"Wang, K., Wei, G. & Liu, D. CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Exp. Hematol. Oncol. 1, 36 (2012).","journal-title":"Exp. Hematol. Oncol."},{"key":"BFncomms6797_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/1074-7613(95)90157-4","volume":"3","author":"P Engel","year":"1995","unstructured":"Engel, P. et al. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3, 39\u201350 (1995).","journal-title":"Immunity"},{"key":"BFncomms6797_CR36","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa051568","volume":"354","author":"MC van Zelm","year":"2006","unstructured":"van Zelm, M. C. et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354, 1901\u20131912 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms6797_CR37","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","volume":"165","author":"S Sato","year":"2000","unstructured":"Sato, S., Hasegawa, M., Fujimoto, M., Tedder, T. F. & Takehara, K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J. Immunol. 165, 6635\u20136643 (2000).","journal-title":"J. Immunol."},{"key":"BFncomms6797_CR38","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI0215078","volume":"109","author":"E Saito","year":"2002","unstructured":"Saito, E. et al. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109, 1453\u20131462 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6797_CR39","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr, T. A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001\u20131010 (2012).","journal-title":"J. Exp. Med."},{"key":"BFncomms6797_CR40","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","volume":"71","author":"K Khan","year":"2012","unstructured":"Khan, K. et al. Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Ann. Rheum. Dis. 71, 1235\u20131242 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFncomms6797_CR41","first-page":"291","volume":"23","author":"R Giacomelli","year":"1996","unstructured":"Giacomelli, R. et al. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. J. Rheumatol. 23, 291\u2013296 (1996).","journal-title":"J. Rheumatol."},{"key":"BFncomms6797_CR42","doi-asserted-by":"publisher","first-page":"10525","DOI":"10.1073\/pnas.0801414105","volume":"105","author":"R Eferl","year":"2008","unstructured":"Eferl, R. et al. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1. Proc. Natl Acad. Sci. USA 105, 10525\u201310530 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6797_CR43","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/art.27382","volume":"62","author":"S Sonnylal","year":"2010","unstructured":"Sonnylal, S. et al. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 62, 1523\u20131532 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","volume":"29","author":"TA Medsger","year":"2003","unstructured":"Medsger, T. A. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum. Dis. Clin. North. Am. 29, 255\u2013273 vi (2003).","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"BFncomms6797_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF00509236","volume":"277","author":"T Krieg","year":"1985","unstructured":"Krieg, T., Perlish, J. S., Fleischmajer, R. & Braun-Falco, O. Collagen synthesis in scleroderma: selection of fibroblast populations during subcultures. Arch. Dermatol. Res. 277, 373\u2013376 (1985).","journal-title":"Arch. Dermatol. Res."},{"key":"BFncomms6797_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaci.2013.07.027","volume":"133","author":"A Otsuka","year":"2014","unstructured":"Otsuka, A. et al. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression. J. Allergy Clin. Immunol. 133, 139\u2013146 e110 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFncomms6797_CR47","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/art.27549","volume":"62","author":"AA Shah","year":"2010","unstructured":"Shah, A. A., Rosen, A., Hummers, L., Wigley, F. & Casciola-Rosen, L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies. Arthritis Rheum. 62, 2787\u20132795 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph, C. G. et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343, 152\u2013157 (2014).","journal-title":"Science"},{"key":"BFncomms6797_CR49","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1365-2133.2012.11055.x","volume":"167","author":"S Noda","year":"2012","unstructured":"Noda, S. et al. Constitutive activation of c-Abl\/protein kinase C-\u03b4\/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma. Br. J. Dermatol. 167, 1098\u20131105 (2012).","journal-title":"Br. J. Dermatol."},{"key":"BFncomms6797_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/hep.23102","volume":"50","author":"Z Tong","year":"2009","unstructured":"Tong, Z. et al. Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology 50, 939\u2013947 (2009).","journal-title":"Hepatology"},{"key":"BFncomms6797_CR51","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1128\/MCB.01320-08","volume":"29","author":"Y Asano","year":"2009","unstructured":"Asano, Y. & Trojanowska, M. Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300\/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta. Mol. Cell. Biol. 29, 1882\u20131894 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFncomms6797_CR52","doi-asserted-by":"publisher","first-page":"34672","DOI":"10.1074\/jbc.M703907200","volume":"282","author":"Y Asano","year":"2007","unstructured":"Asano, Y., Czuwara, J. & Trojanowska, M. Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300\/CREB-binding protein-associated factor-dependent acetylation. J. Biol. Chem. 282, 34672\u201334683 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6797_CR53","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/art.27220","volume":"62","author":"G Farina","year":"2010","unstructured":"Farina, G., Lafyatis, D., Lemaire, R. & Lafyatis, R. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum. 62, 580\u2013588 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/ard.2007.086850","volume":"68","author":"G Farina","year":"2009","unstructured":"Farina, G. et al. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta. Ann. Rheum. Dis. 68, 435\u2013441 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFncomms6797_CR55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/jcs.01731","volume":"118","author":"EG Canty","year":"2005","unstructured":"Canty, E. G. & Kadler, K. E. Procollagen trafficking, processing and fibrillogenesis. J. Cell. Sci. 118, 1341\u20131353 (2005).","journal-title":"J. Cell. Sci."},{"key":"BFncomms6797_CR56","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1359\/jbmr.2002.17.7.1180","volume":"17","author":"A Corsi","year":"2002","unstructured":"Corsi, A. et al. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17, 1180\u20131189 (2002).","journal-title":"J. Bone Miner. Res."},{"key":"BFncomms6797_CR57","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/j.1365-2133.2010.10008.x","volume":"163","author":"JT Yeh","year":"2010","unstructured":"Yeh, J. T. et al. Impaired skin wound healing in lumican-null mice. Br. J. Dermatol. 163, 1174\u20131180 (2010).","journal-title":"Br. J. Dermatol."},{"key":"BFncomms6797_CR58","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1083\/jcb.151.4.779","volume":"151","author":"Y Ezura","year":"2000","unstructured":"Ezura, Y., Chakravarti, S., Oldberg, A., Chervoneva, I. & Birk, D. E. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell Biol. 151, 779\u2013788 (2000).","journal-title":"J. Cell Biol."},{"key":"BFncomms6797_CR59","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3899\/jrheum.100956","volume":"38","author":"RL Manno","year":"2011","unstructured":"Manno, R. L., Wigley, F. M., Gelber, A. C. & Hummers, L. K. Late-age onset systemic sclerosis. J. Rheumatol. 38, 1317\u20131325 (2011).","journal-title":"J. Rheumatol."},{"key":"BFncomms6797_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1183\/09031936.00106008","volume":"34","author":"MJ Overbeek","year":"2009","unstructured":"Overbeek, M. J. et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur. Respir. J. 34, 371\u2013379 (2009).","journal-title":"Eur. Respir. J."},{"key":"BFncomms6797_CR61","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/art.30159","volume":"63","author":"E Hsu","year":"2011","unstructured":"Hsu, E. et al. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum. 63, 783\u2013794 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFncomms6797_CR62","doi-asserted-by":"crossref","unstructured":"Shima, Y. et al. Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab. Mod. Rheumatol PMID 24533556 (2014).","DOI":"10.1007\/s10165-013-0855-6"},{"key":"BFncomms6797_CR63","doi-asserted-by":"crossref","unstructured":"Jordan, S. et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann. Rheum. Dis. PMID 24442885 (2014).","DOI":"10.1136\/annrheumdis-2013-204522"},{"key":"BFncomms6797_CR64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","volume":"27","author":"S Sato","year":"2001","unstructured":"Sato, S., Hasegawa, M. & Takehara, K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J. Dermatol. Sci. 27, 140\u2013146 (2001).","journal-title":"J. Dermatol. Sci."},{"key":"BFncomms6797_CR65","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1096\/fasebj.12.12.1151","volume":"12","author":"D Kothapalli","year":"1998","unstructured":"Kothapalli, D., Hayashi, N. & Grotendorst, G. R. Inhibition of TGF-beta-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle. FASEB J. 12, 1151\u20131161 (1998).","journal-title":"FASEB J."},{"key":"BFncomms6797_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2004.11.005","volume":"1","author":"Y Oishi","year":"2005","unstructured":"Oishi, Y. et al. Kr\u00fcppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1, 27\u201339 (2005).","journal-title":"Cell Metab."},{"key":"BFncomms6797_CR67","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.1038\/sj.onc.1203360","volume":"18","author":"F Shirasaki","year":"1999","unstructured":"Shirasaki, F., Makhluf, H. A., LeRoy, C., Watson, D. K. & Trojanowska, M. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18, 7755\u20137764 (1999).","journal-title":"Oncogene"},{"key":"BFncomms6797_CR68","first-page":"281","volume":"338","author":"KK Wu","year":"2006","unstructured":"Wu, K. K. Analysis of protein-DNA binding by streptavidin-agarose pulldown. Methods Mol. Biol. 338, 281\u2013290 (2006).","journal-title":"Methods Mol. Biol."},{"key":"BFncomms6797_CR69","first-page":"710","volume":"118","author":"S Nishimura","year":"2008","unstructured":"Nishimura, S. et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J. Clin. Invest. 118, 710\u2013721 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6797_CR70","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1182\/blood-2011-09-381400","volume":"119","author":"S Nishimura","year":"2012","unstructured":"Nishimura, S. et al. In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling. Blood 119, e45\u2013e56 (2012).","journal-title":"Blood"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms6797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6797","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T02:27:04Z","timestamp":1672972024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms6797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,23]]}},"alternative-id":["BFncomms6797"],"URL":"https:\/\/doi.org\/10.1038\/ncomms6797","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]},"assertion":[{"value":"10 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5797"}}